We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| TScan Therapeutics Inc | NASDAQ:TCRX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.73 | 9.46% | 8.45 | 8.20 | 8.96 | 8.70 | 7.75 | 7.75 | 263,587 | 23:10:34 |
From May 2023 to May 2024
By Sabela Ojea
Marvell Technology on Thursday forecast substantial growth ahead thanks in part to artificial intelligence.
Shares of the data infrastructure semiconductor solutions provider climbed 17% to $57.81 in after-hours trading.
Workday posted better-than-expected first-quarter results and improved its outlook. Shares of the cloud software company rose 8.2% to $212.50 in after-hours trading.
Gap reported a narrower loss in its latest quarter and said its gross margins are improving. Shares of the retail chain climbed 14% to $8.49 in after-hours trading.
TScan Therapeutics said it commenced an underwritten public offering of its voting common stock. Shares of the biopharmaceutical company fell 7.4% to $2.25 in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
May 25, 2023 19:35 ET (23:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year TScan Therapeutics Chart |
1 Month TScan Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
